Spruce Biosciences, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Spruce Biosciences, Inc. (SPRB) reported Adjustments to Additional Paid in Capital, Warrant Issued of $57.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-22.
Discontinued
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2021-03-22
- Spruce Biosciences, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-09-30 was $37.00K.
- Spruce Biosciences, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $57.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2019-12-31 | $57.00K 10-K · filed 2021-03-22 | |
| 2019-09-30 | $37.00K 10-Q · filed 2020-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |